Skip to main content

Table 3 EORTC quality of life scores by treatment arm

From: Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial

 

Mean baseline score (SD)

Mean 6 weeks score (SD)

Mean difference (SD)

 
 

3-weekly

Weekly

3-weekly

Weekly

3-weekly

Weekly

P value*

 

N = 48

N = 41

N = 48

N = 41

   

Global QoL

62.8 (22.8)

64.0 (21.2)

67.9 (16.0)

60.0 (19.0)

5.0 (26.0)

-3.5 (20.5)

0.03

Functional scales

       

Physical functioning

86.3 (16.6)

81.9 (19.6)

82.3 (16.8)

78.0 (18.0)

-4.0 (11.8)

-3.9 (14.3)

0.64

Role functioning

84.7 (22.2)

79.3 (26.0)

84.0 (21.2)

72.0 (23.4)

-0.7 (22.3)

-7.3 (24.7)

0.02

Emotional functioning

59.2 (23.5)

60.4 (22.2)

71.5 (19.1)

64.8 (24.4)

12.3 (21.6)

4.5 (18.5)

0.055

Cognitive functioning

88.9 (14.7)

89.8 (21.0)

90.3 (14.9)

83.7 (23.7)

1.4 (19.1)

-6.1 (18.5)

0.055

Social functioning

81.6 (21.5)

80.5 (25.0)

80.2 (26.6)

69.5 (28.6)

-1.4 (32.8)

-11.0 (29.7)

0.07

Symptoms

       

Pain

23.6 (27.9)

26.0 (25.3)

15.3 (19.1)

22.4 (19.9)

-8.3 (23.8)

-3.7 (19.9)

0.08

Loss of appetite

13.2 (23.6)

13.8 (23.5)

15.3 (21.7)

14.6 (21.1)

2.1 (29.5)

0.8 (24.1)

0.86

Constipation

13.9 (16.6)

15.4 (24.8)

17.7 (23.9)

20.0 (28.0)

4.3 (26.6)

5.8 (31.9)

0.71

Financial

18.8 (26.5)

19.5 (30.7)

15.3 (23.8)

35.0 (33.3)

-3.5 (22.0)

15.4 (37.3)

0.0007

Fatigue

19.4 (19.7)

24.1 (25.0)

31.6 (19.0)

36.9 (20.6)

12.2 (16.0)

12.7 (26.1)

0.39

Nausea/vomiting

5.2 (12.0)

7.3 (14.5)

17.4 (25.0)

19.5 (22.6)

12.2 (24.0)

12.2 (21.4)

0.87

Sleeping disturbance

27.7 (28.9)

40.0 (31.3)

22.9 (26.8)

29.2 (32.2)

-5.7 (28.1)

-10.8 (28.6)

0.90

Diarrhoea

5.6 (14.3)

2.6 (9.0)

9.0 (17.9)

12.2 (20.8)

3.5 (19.7)

9.4 (20.2)

0.31

Dyspnoea

5.6 (12.6)

14.6 (25.9)

9.0 (16.5)

19.2 (21.2)

3.5 (15.7)

4.2 (25.2)

0.10

  1. SD: standard deviation; * bold p-values are statistically significant